Tumour histology and primary site but not MDM2 amplification levels are prognostic for clinical outcomes in well differentiated and dedifferentiated liposarcoma

被引：0
|
作者：
Chew, W. H. W. [1 ]
Chan, J. Y. [1 ]
Goh, W. L. [1 ]
Lim, J. H. C. [2 ]
Tan, S. H. [2 ]
Somasundaram, N. [1 ]
Poon, E. Y. L. [1 ]
Lim, A. S. T. [3 ]
Tan, M. H. [4 ]
Soo, K. C. [5 ]
Teo, M. [5 ]
Tay, T. K. Y. [6 ]
Selvarajan, S. [6 ]
Sittampalam, K. [6 ]
Quek, R. [1 ]
机构：
[1] Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore
[2] Natl Canc Ctr Singapore, Div Clin Trials & Epidemiol Sci, Singapore, Singapore
[3] Singapore Gen Hosp, Dept Mol Pathol, Singapore, Singapore
[4] Singapore Gen Hosp, Dept Orthopaed Surg, Singapore, Singapore
[5] Natl Canc Ctr Singapore, Div Surg Oncol, Singapore, Singapore
[6] Singapore Gen Hosp, Dept Anat Pathol, Singapore, Singapore
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
487O
引用
收藏
页码：150 / 150
页数：1
相关论文
共 50 条
  • [1] Degree of MDM2 Amplification Affects Clinical Outcomes in Dedifferentiated Liposarcoma
    Bill, Kate Lynn J.
    Seligson, Nathan D.
    Hays, John L.
    Awasthi, Achal
    Demoret, Bryce
    Stets, Colin W.
    Duggan, Megan C.
    Bupathi, Manojkumar
    Brock, Guy N.
    Millis, Sherri Z.
    Shakya, Reena
    Timmers, Cynthia D.
    Wakely, Paul E., Jr.
    Pollock, Raphael E.
    Chen, James L.
    ONCOLOGIST, 2019, 24 (07): : 989 - 996
  • [2] DEGREE OF MDM2 AMPLIFICATION AFFECTS CLINICAL OUTCOMES IN DEDIFFERENTIATED LIPOSARCOMA.
    Seligson, N. D.
    Bill, K. L. J.
    Hays, J. L.
    Demoret, B.
    Stets, C. W.
    Duggan, M.
    Bupathi, M.
    Shakya, R.
    Timmers, C.
    Walely, P. E.
    Pollock, R. E.
    Chen, J. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S38 - S38
  • [3] MDM2 Copy Numbers in Well-Differentiated and Dedifferentiated Liposarcoma
    Ware, Patrick L.
    Snow, Anthony N.
    Gvalani, Maya
    Pettenati, Mark J.
    Qasem, Shadi A.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2014, 141 (03) : 334 - 341
  • [4] Prognostic relevance of myogenic differentiation, FNCLCC grading and MDM2 amplification levels in well-differentiated and dedifferentiated liposarcoma: A study of 70 cases
    Lecoutere, E.
    Van Dorpe, J.
    Verbeke, S.
    van Gorp, J.
    Flucke, U.
    Van Bockstal, M.
    Ferdinande, L.
    Creytens, D.
    VIRCHOWS ARCHIV, 2016, 469 : S215 - S215
  • [5] Relevance of FNCLCC Grade and MDM2 Amplification Levels in Dedifferentiated Liposarcoma
    Jour, G.
    Gullett, A.
    Liu, M.
    Hoch, B. L.
    MODERN PATHOLOGY, 2014, 27 : 19A - 19A
  • [6] Relevance of FNCLCC Grade and MDM2 Amplification Levels in Dedifferentiated Liposarcoma
    Jour, G.
    Gullet, A.
    Liu, M.
    Hoch, B. L.
    LABORATORY INVESTIGATION, 2014, 94 : 19A - 19A
  • [7] Dedifferentiated melanoma with MDM2 gene amplification mimicking dedifferentiated liposarcoma
    Yousef, Samer
    Joy, Christopher
    Velaiutham, Shanta
    Maclean, Fiona M.
    Harraway, James
    Gill, Anthony J.
    Vargas, Ana Cristina
    PATHOLOGY, 2022, 54 (03) : 371 - 374
  • [8] Prognostic impact of the MDM2/HMGA2 ratio and clinicopathological factors in well-differentiated and dedifferentiated liposarcoma
    Yamashita, Kyoko
    Kohashi, Kenichi
    Yamada, Yuichi
    Akatsuka, Shinya
    Oda, Yoshinao
    MODERN PATHOLOGY, 2019, 32
  • [9] Prognostic impact of the MDM2/HMGA2 ratio and clinicopathological factors in well-differentiated and dedifferentiated liposarcoma
    Yamashita, Kyoko
    Kohashi, Kenichi
    Yamada, Yuichi
    Akatsuka, Shinya
    Oda, Yoshinao
    LABORATORY INVESTIGATION, 2019, 99
  • [10] Intraperitoneal dedifferentiated liposarcoma showing MDM2 amplification: case report
    Grifasi, Carlo
    Calogero, Armando
    Carlomagno, Nicola
    Campione, Severo
    D'Armiento, Francesco Paolo
    Renda, Andrea
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2013, 11
12345